Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 186.29 USD 0.49% Market Closed
Market Cap: 9.5B USD
Have any thoughts about
Charles River Laboratories International Inc?
Write Note
CRL
/
Cash Flow Statement
/
Change in Deffered Taxes

Charles River Laboratories International Inc
Change in Deffered Taxes

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Charles River Laboratories International Inc
Change in Deffered Taxes Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Deffered Taxes CAGR 3Y CAGR 5Y CAGR 10Y
Charles River Laboratories International Inc
NYSE:CRL
Change in Deffered Taxes
-$48.6m
CAGR 3-Years
-65%
CAGR 5-Years
-15%
CAGR 10-Years
-19%
Thermo Fisher Scientific Inc
NYSE:TMO
Change in Deffered Taxes
-$1.7B
CAGR 3-Years
-49%
CAGR 5-Years
-32%
CAGR 10-Years
-7%
Danaher Corp
NYSE:DHR
Change in Deffered Taxes
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Change in Deffered Taxes
-$36.9m
CAGR 3-Years
-46%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Change in Deffered Taxes
-$64m
CAGR 3-Years
N/A
CAGR 5-Years
24%
CAGR 10-Years
10%
IQVIA Holdings Inc
NYSE:IQV
Change in Deffered Taxes
-$266m
CAGR 3-Years
-39%
CAGR 5-Years
-12%
CAGR 10-Years
-30%
No Stocks Found

Charles River Laboratories International Inc
Glance View

Market Cap
9.5B USD
Industry
Life Sciences Tools & Services
Economic Moat
None

Nestled within the intricate maze of the global life sciences sector, Charles River Laboratories International Inc. stands as a pivotal player. With a legacy dating back to 1947, the company has carved out a niche in providing essential research models and preclinical services that underpin crucial drug development processes. Its journey began by breeding laboratory animals, an unassuming yet vital task that feeds the robust pipeline of scientific inquiry and pharmaceutical innovation. This foundational service, involving the provision of research models such as rats and mice, forms the bedrock upon which the company built its expansive portfolio. It primes the pumps of early-stage research for pharmaceutical and biotechnology firms, offering a reliable source of high-quality, disease-specific models that are indispensable for preclinical trials. Today, Charles River Laboratories has evolved into a comprehensive partner for the biomedical and pharmaceutical industries. It derives its revenue by encompassing a broad portfolio of offerings beyond animal models, venturing into the vast domain of comprehensive drug discovery and safety testing for new pharmaceuticals. This makes the company instrumental in speeding up the development pipeline—from concept to the cusp of clinical trials. By providing everything from lab services, safety assessments, and manufacturing support, Charles River facilitates the journey of a drug from an embryonic idea to a tangible, market-ready solution, all while ensuring compliance with strict regulatory standards. This integration across verticals not only enriches its value proposition but ensures a steady stream of revenue across various stages of the drug development lifecycle.

CRL Intrinsic Value
232.86 USD
Undervaluation 20%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Charles River Laboratories International Inc's Change in Deffered Taxes?
Change in Deffered Taxes
-48.6m USD

Based on the financial report for Sep 28, 2024, Charles River Laboratories International Inc's Change in Deffered Taxes amounts to -48.6m USD.

What is Charles River Laboratories International Inc's Change in Deffered Taxes growth rate?
Change in Deffered Taxes CAGR 10Y
-19%

Over the last year, the Change in Deffered Taxes growth was -29%. The average annual Change in Deffered Taxes growth rates for Charles River Laboratories International Inc have been -65% over the past three years , -15% over the past five years , and -19% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.